跳至主要内容
临床试验/NCT04509089
NCT04509089已完成不适用

Establishing Correlation Between Non-invasive Pulmonary Blood Pressure Readings and Swan-Ganz Results

Suremedix Ltd2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Suremedix Ltd
入组人数
15
试验地点
2
主要终点
Pressure waveform

研究概览

简要总结

Pulmonary hypertension (PH) is prognostic indicator in heart failure patients for poor outcome, however, it is challenging for monitoring. The current study is designed to explore whether data generated using Suremedix Device including a pump and non-invasive sensors including, chest motion sensor, photoplethysmography (PPG), and Electrocardiography (ECG), can be used to identify detectable oscillations that are correlated with the mean, the diastolic and the systolic pressure values of the pulmonary artery, as measured using the gold-standard Swan-Ganz method.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Heart Failure patient scheduled for right heart catheterization (Swan-Ganz)
  • Age range: 18 - 80 years
  • Pulmonary artery systolic pressure values ≤50 mmHg according to Swan - Ganz measurement
  • Able and willing to sign informed consent

排除标准

  • History or current diagnosis of asthma or any other significant pulmonary disease
  • Jugular access site
  • Atrial fibrillation
  • Prior lung volume reduction surgery, lobectomy or pneumonectomy, or lung transplantation
  • Requirement for any ventilator support (including CPAP or BPAP)
  • Use of long-term oxygen therapy
  • Known upper airway obstruction
  • Known susceptibility to pneumothorax or pneumothorax in the medical history
  • Chest surgery or pacemaker implantation in the prior 6 months
  • Significant primary valvular disease
  • Major cardiovascular event within the prior 3 months
  • Current heavy smoker (more than one pack per day)
  • Any diagnosed respiratory tract infection (including upper respiratory tract), airway or lung disease or COPD exacerbation in the prior 3 months
  • Female patient pregnant or breast-feeding or planning to be pregnant in the next year
  • Diagnosis of Obstructive Sleep Apnea
  • Unexplained muscle weakness. Unable to comfortably lie down for 30 minutes
  • Current hospitalization due to CHF deterioration
  • Patients with a Body Mass Index (BMI) ≥ 40kg/m2
  • Any condition that the PI believes could interfere with the intent of the study or would make participation not in the best interest of the patient

结局指标

主要结局

Pressure waveform

时间窗: 15 minutes

Correlation between specific changes observed in the pressure waveform recorded by the SureMedix Device and the mean, diastolic and systolic pressure values of the pulmonary artery as measured using the gold-standard Swan-Ganz method.

次要结局

未报告次要终点

研究者

发起方
Suremedix Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Establishing Correlation Between Non-invasive... | 临床试验